James J. Harding, Jia Fan, Do-Youn Oh, Hye Jin Choi, Jin Won Kim, Heung-Moon Chang, Lequn Bao, Hui-Chuan Sun, Teresa Macarulla, Feng Xie, Jean-Philippe Metges, Jieer Ying, John Bridgewater, Harpreet Singh Wasan, Michel Pierre Ducreux, Zinan Bao, Phillip M. Garfin, Douglas S. Fuller, Parveen Jayia, Shubham Pant. "Landmark analysis of overall survival (OS) by objective response in patients (pts) with previously treated, advanced HER2-positive biliary tract cancer (BTC): Post hoc analysis of the HERIZON-BTC-01 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.545